Skip to main content
. 2012 Sep 24;15(4):273–278. doi: 10.1111/j.1477-2574.2012.00566.x

Table 2.

Operative outcomes in 148 living donors and 160 tumour patients undergoing resection using an upper midline incision

Living donors (n = 148) Patients (n = 160)
Types of liver resection, n (%)

 Right hepatectomy without MHV 138 (93.2%) 65 (40.6%)

 Right hepatectomy with MHV 8 (5.4%) 5 (3.1%)

 Right posterior sectionectomy without RHV 0 15 (9.4%)

 Right posterior sectionectomy with RHV 0 13 (8.1%)

 Right anterior sectionectomy 0 4 (2.5%)

 Left medial sectionectomy 0 1 (0.6%)

 Central bisectionectomy 0 2 (1.3%)

 Right trisectionectomy 0 3 (1.9%)

 Left hepatectomy without MHV 0 22 (13.8%)

 Left hepatectomy with MHV 1 (0.7%) 9 (5.6%)

 Left hepatectomy with caudate lobe and MHV 1 (0.7%) 3 (1.9%)

 Left lateral sectionectomy 0 5 (3.1%)

 Caudate lobectomy 0 2 (1.3%)

 Bisegmentectomy (segments V and VI) 0 7 (4.4%)

 Tumorectomy within one segment 0 4 (2.5%)

Operation time, min

  Mean ± SD 213.2 ± 37.7 170.2 ± 37.7

  Median 208 168

  Range 156–305 54–260

Blood loss, ml

  Mean ± SD 311.4 ± 145.5 552.4 ± 215.5

  Median 300 575

  Range 100–600 100–1000

 Intraoperative blood transfusion, n 0 0

Intensive care unit stay, days

  Mean ± SD 0.1 ± 0.5 0.2 ± 0.6

  Median 0 0

  Range 0–2 0–4

Postoperative hospital stay, days

  Mean ± SD 7.9 ± 1.7 8.3 ± 1.9

  Median 7 8

  Range 7–17 6–17

Period of analgesia use, days

  Mean ± SD 3.1 ± 1.9 2.9 ± 2.2

  Median 3 3

  Range 1–8 2–9

MHV, middle hepatic vein; RHV, right hepatic vein; SD: standard deviation.